CVS recently announced plans to open about a dozen smaller locations that focus primarily on pharmacy and limited front end. This move comes as little surprise to some, given that CVS has been closing larger stores over the past three years. Let’s delve into the details provided by news sources and explore the potential implications of this shift.

Store Details

The new stores will average less than 5,000 square feet and be strategically located in select neighborhoods. Unlike traditional CVS stores, these smaller locations will not sell greeting cards or groceries. Instead, they will offer select over-the-counter medications tailored to the community’s needs. The smaller stores will be full-service retail pharmacy locations offering prescription dispensing, immunizations, and other pharmacist-provided healthcare services.

Considerations

1. Revenue Impact: Historically, 20% to 30% of CVS store revenue came from the front end. These smaller locations will limit that revenue stream, but they may also reduce operational costs.
2. Staffing and Inventory: The smaller format may require fewer staff members and reduce inventory-related issues, such as theft.
3. Competition: Retail competition from mass merchandisers, discount clubs, and online marketplaces may have influenced this change. However, CVS’s pharmacy dispensing and services business isn’t without competition either.
4. PBM Network Access: CVS Caremark (PBM) pharmacy network access could strategically benefit from these smaller stores, allowing CVS to meet access requirements while potentially excluding competitors.

Questions and Speculations

• Will CVS’s strategic placement of smaller stores focus on locations near healthcare centers or rural areas with potentially unmet healthcare needs?
• Will these smaller stores incorporate drive-thru pharmacy services?
• What role, if any, will the HealthHub concept play in the smaller store footprint?
• Could this smaller store format become a new trend for chain pharmacies?
• Is CVS exploring this option due to its shift towards a cost-plus reimbursement model?

Conclusion

CVS’s experiment with smaller store sizes is an interesting development in the retail pharmacy landscape. While there are potential benefits and challenges, it will be crucial to monitor the performance of these smaller stores and their impact on CVS’s overall strategy. As the healthcare and retail industries continue to evolve, so too must the business models of major players like CVS.